Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Press Releases
Lucid Diagnostics  
April 9, 2025

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

avatar profile Olean Times Herald

Olean Times Herald


Local & Social